The New York State Department of Health recently awarded The Mount Sinai Hospital’s Cardiac Catheterization (Cath) Laboratory the highest “two-star” safety rating for percutaneous coronary interventions (PCI) in overall and nonemergency cases. This marks the 16th consecutive year that the Cath Lab, or one of its physicians, has received this prestigious two-star rating for safety when performing PCI. The minimally invasive procedure, also known as angioplasty, is used to diagnose and treat patients with heart disease or blocked arteries.
Mount Sinai’s safety rating—significantly higher than New York’s statewide average while performing the highest number of procedures—is included in a new report titled “Percutaneous Coronary Interventions (PCI) in New York State 2009-2011.” The study tracked the outcomes of 160,065 patients who underwent PCI at one of 59 New York cardiac catheterization labs between December 1, 2008, and November 30, 2011.
“Our long track record of success in offering the highest level of patient safety and excellence in patient care now spans 16 years,” says Samin K. Sharma, MD, Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital. “At Mount Sinai Heart’s Cardiac Cath Lab we put our patients first.”
During the three-year period, Mount Sinai performed the highest number of PCI procedures in New York State (14,525), yet its risk-adjusted mortality rate, or RAMR, for all cases (0.71 percent) was significantly lower than the statewide average (0.91 percent). Mount Sinai’s mortality rates for nonemergency cases (0.44 percent) was significantly lower than the statewide average (0.57 percent), as well.
The New York State data also highlight the leading performance of Annapoorna S. Kini, MD, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital, who was one of four interventional cardiologists—among nearly 500 in the state—to be awarded the highest two-star safety rating while performing 3,063 PCI cases.
“This new report reflects our leadership in the field of interventional cardiology by measuring our successful results and the high-quality patient care we provide every day,” says Dr. Kini.
Adds Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital: “The leadership, expertise, and compassion that Dr. Sharma, Dr. Kini, and our Cardiac Cath Lab team have for their patients shines through once again in these latest patient safety results.”